Register entry
- Registered sites
- 0
- Active NDC listings
- 9
- Live patents
- 43
- Exclusivities
- 3
- Countries
- 0
Catalogue
Drug listings by form and route
99 active NDC listings: 9 human prescription drug. By marketing category: NDA 9.
| Dosage form | NDCs |
|---|---|
| tablet | 4 |
| capsule | 2 |
| solution | 2 |
| tablet, film coated | 1 |
| Route | NDCs |
|---|---|
| oral | 9 |
| Labeller name on the listing | NDCs |
|---|---|
| mirum pharmaceuticals inc. | 9 |
Exclusivity
Patents and exclusivities
43| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 11260053 | LIVMARLImaralixibat chloride | use | May 2031 |
| 10512657 | LIVMARLImaralixibat chloride | use | Oct 2032 |
| 11229661 | LIVMARLImaralixibat chloride | use | Oct 2032 |
| 11376251 | LIVMARLImaralixibat chloride | use | Oct 2032 |
| 12350267 | LIVMARLImaralixibat chloride | use | Oct 2032 |
| 11229647 | LIVMARLImaralixibat chloride | use | Feb 2040 |
| 11497745 | LIVMARLImaralixibat chloride | use | Feb 2040 |
| 11918578 | LIVMARLImaralixibat chloride | use | Feb 2040 |
| 12599602 | LIVMARLImaralixibat chloride | use | Feb 2040 |
| 12296050 | LIVMARLImaralixibat chloride | product | Oct 2043 |
| Product | Exclusivity | Until |
|---|---|---|
| LIVMARLIMARALIXIBAT CHLORIDE | I-938 New indication | Mar 2027 |
| LIVMARLIMARALIXIBAT CHLORIDE | ODE-471 Orphan drug | Mar 2031 |
| LIVMARLIMARALIXIBAT CHLORIDE | ODE-490 Orphan drug | Jul 2031 |
Catalogue
Marketed products
9| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| CHOLBAM | cholic acid | capsule, oral | 79378-001NDA |
| CHOLBAM | cholic acid | capsule, oral | 79378-002NDA |
| CTEXLI | chenodiol | tablet, film coated, oral | 79378-310NDA |
| Livmarli | maralixibat chloride | solution, oral | 79378-110NDA |
| Livmarli | maralixibat chloride | solution, oral | 79378-111NDA |
| Livmarli | maralixibat chloride | tablet, oral | 79378-210NDA |
| Livmarli | maralixibat chloride | tablet, oral | 79378-215NDA |
| Livmarli | maralixibat chloride | tablet, oral | 79378-220NDA |
| Livmarli | maralixibat chloride | tablet, oral | 79378-230NDA |
Enquiry
Common questions
- Is Mirum Pharmaceuticals Inc. FDA approved?
- Mirum Pharmaceuticals Inc. holds no registered establishment of its own; 9 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Mirum Pharmaceuticals Inc. make?
- 9 products are listed under Mirum Pharmaceuticals Inc. in the openFDA NDC Directory, most often as tablet; capsule; solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.